Follicular Lymphoma News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Imbruvica Only Moderately Effective in Relapsed Follicular Lymphoma Patients, Phase 2 Trial Shows - Lymphoma News Today



Lymphoma News Today
 
Imbruvica Only Moderately Effective in Relapsed Follicular Lymphoma Patients, Phase 2 Trial Shows 
Lymphoma News Today
It is an oral therapy approved for treatment of many B-cell malignancies, including chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenström macroglobulinemia. Imbruvica was also recently approved for the treatment of chronic graft-versus ...

 


Autologous transplant in follicular lymphoma after treatment failure - Lymphoma Hub



Lymphoma Hub
 
Autologous transplant in follicular lymphoma after treatment failure 
Lymphoma Hub
Carla Casulo of the Wilmont Cancer Institute and colleagues completed a multicenter study comparing outcomes in follicular lymphoma (FL) patients with early treatment failure after frontline rituximab-based chemotherapy, who received autologous stem ...

 


Chemo/Radioimmunotherapy Treatment Strategy Induces 90% PFS at 3 Years in Follicular Lymphoma - Targeted Oncology



Targeted Oncology
 
Chemo/Radioimmunotherapy Treatment Strategy Induces 90% PFS at 3 Years in Follicular Lymphoma 
Targeted Oncology
Patients had stage III, IV, or bulky stage II follicular lymphoma, grades 1, 2, or 3a. The median age among enrolled patients was 52 (range, 46-60) and 52% were female. The majority (62%) of patients had an ECOG performance status of 0. Twenty-four ...

 


What is silent cancer follicular lymphoma, and how do you know if you have it? - Telegraph.co.uk



Telegraph.co.uk
 
What is silent cancer follicular lymphoma, and how do you know if you have it? 
Telegraph.co.uk
Lady Mendelsohn told how like many sufferers she has decided to "watch and wait", rather than treat the disease. She is managing her illness with regular scans and blood tests. If the tumours are growing she will begin chemotherapy and radiotherapy ...
What is follicular lymphoma, what are the symptoms of Nicola Mendelsohn's blood cancer and what's the life expectancy? The Sun
'I Want to Use My Voice to Help:' Facebook Exec Reveals Incurable Cancer Fortune
Facebook executive has 'incurable' cancer BBC News
The Independent  -Daily Mail 
all 21 news articles » 


FDA Approval Sought for Duvelisib in CLL, Follicular Lymphoma - OncLive



OncLive
 
FDA Approval Sought for Duvelisib in CLL, Follicular Lymphoma 
OncLive
A new drug application (NDA) has been submitted to the FDA for duvelisib for a full approval for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and an accelerated approval for the ...
Verastem takes AbbVie's blood cancer castoff to the FDA Endpoints News
At Verastem, Infinity's Former Blood Cancer Drug Heads to FDA Xconomy
Verastem submits US marketing application for lead candidate duvelisib; shares ahead 7% premarket Seeking Alpha

all 5 news articles » 


Umbraslisib Shows Encouraging Early Activity in CLL and Lymphoma - Targeted Oncology



Targeted Oncology
 
Umbraslisib Shows Encouraging Early Activity in CLL and Lymphoma 
Targeted Oncology
In an accompanying editorial, Jacqueline Claudia Barrientos, MD, associate professor with the Karches Center for Oncology Research at The Feinstein Institute for Medical Research, wrote that PI3K inhibitors fell out of favor after idelalisib (Zydelig ...

 


Progression of disease may be effective endpoint for poor survival in lymphoma subtype - Healio



Progression of disease may be effective endpoint for poor survival in lymphoma subtype 
Healio
ATLANTA ? Progression of disease within 24 months of diagnosis among patients treated with chemoimmunotherapy appears to be an effective early clinical endpoint of poor survival in follicular lymphoma and should be utilized to identify patients for ...

 


Follicular Lymphoma: Optimizing Novel Agent Therapy - OncLive



OncLive
 
Follicular Lymphoma: Optimizing Novel Agent Therapy 
OncLive
Ian W. Flinn, MD, PhD: There are a couple of other PI3 kinase inhibitors in development. One is duvelisib, which is a delta inhibitor. It also has inhibition of the gamma isoform. That may broaden its ability to diseases outside of follicular lymphoma ...

and more » 


Immunotherapy in the Treatment of Follicular Lymphoma - OncLive



OncLive
 
Immunotherapy in the Treatment of Follicular Lymphoma 
OncLive
Grzegorz S. Nowakowski, MD: I'd probably start by saying that if you look at follicular lymphoma, this should be the prime target for immunotherapy. We know about the role of the microenvironment in this disease; it has been extensively studied with ...

and more » 


Follicular Lymphoma: Novel Approaches With Rituximab - OncLive



OncLive
 
Follicular Lymphoma: Novel Approaches With Rituximab 
OncLive
As Peter has mentioned, the microenvironment in follicular lymphoma is critically important. How we target that?there are probably various mechanisms?and whether we use a combination of approaches is something that's currently under investigation ...

and more »